Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the fourth quarter of 2024, reporting an increase in revenues and adjusted profit.
Fourth-quarter revenue increased 10% year-over-year to $1.01 billion; CooperVision and CooperSurgical revenues grew 9% and 12%, respectivelyOn a reported basis, earnings per share was $0.58 in Q4, up 38% from last year’s fourth quarterUnadjusted earnings per share moved up 19% annually to $1.04 during the three monthsNet income increased to $117.5 million in the October quarter from $84.5 million a year earlierQ4 gross margin advanced to 67% from 65% the year-ago quarter; operating margin rose to 19% from 15%Operating cash flow and capital expenditures came in at $268.1 million and $139.9 million, respectively, resulting in free cash flow of $128.2 millionFor fiscal 2024, the company expects total revenue to be $4.08-4.16 billion, and organic growth of 6-8%
The post Earnings Summary: A snapshot of CooperCompanies (COO) Q4 2024 results first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
